- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06340009
MIME THERAPY vs MOTOR IMAGERY TECHNIQUE in Bell's Palsy
March 25, 2024 updated by: Riphah International University
Comparison of Mime Therapy and Motor Imagery Technique on Facial Disability in Bell's Palsy.
Bell's palsy, characterized by unilateral paralysis/paresis of facial muscles, is a condition with a significant impact on individuals' lives.
It was first identified by scientist Sir Charles Bell, and its sudden onset can lead to social, psychological, and emotional distress.
Left untreated, Bell's palsy can have long-lasting effects on a patient's quality of life, including loss of facial muscle control, emotional stress, and communication difficulties.
Rehabilitation protocols encompass various physical therapy techniques, among which Mime therapy and Motor imagery technique have shown promise.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
While rehabilitation protocols have shown promise in enhancing facial muscle control, reducing disability, and preventing long-term complications, there remains a critical gap in the literature regarding the comparative effectiveness of various rehabilitation techniques.
Currently, there is limited empirical evidence to guide healthcare professionals in selecting the most suitable rehabilitation approach for individual patients.
The purpose of this study is to address this gap in knowledge by comparing two specific rehabilitation techniques: Mime therapy and Motor imagery technique.
Understanding which of these rehabilitation techniques is more effective can significantly influence clinical practice and patient care.
By conducting a systematic comparison, this study aims to provide evidence-based recommendations to healthcare professionals in selection of appropriate rehabilitation protocol for Bell's palsy patients.
Study Type
Interventional
Enrollment (Estimated)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ayesha Afridi, PhD*
- Phone Number: 03325962212
- Email: afridi.ayesha@gmail.com
Study Contact Backup
- Name: Mulazam Imran, MS-NMPT*
- Phone Number: 03236791525
- Email: mulazimimran04@gmail.com
Study Locations
-
-
-
Sargodha, Pakistan
- Recruiting
- Muzaffar Hospital
-
Contact:
- Mulazam Imran, MS-NMPT*
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age 20-40 years
- Both male and female
- Patients diagnosed with Bell's Palsy
- Paralysis/paresis of all muscle groups of one side of face
Exclusion Criteria:
- Patients diagnosed with facial palsy
- Patients with impaired cognition
- Patients diagnosed with other neurological diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mime therapy group
Mime therapy focuses on improving facial symmetry and muscle control through self-massage, breathing exercises, eye and lip closure exercises, letter and word exercises, and expression exercises in front of mirror
|
|
Active Comparator: motor imagery group
Motor imagery technique involves mental rehearsal of motor activities, activating similar brain regions as actual movements, which enhances neuroplasticity.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
House-Brackmann Scale (HBS)
Time Frame: week 6
|
A widely used scale to assess facial nerve dysfunction.Grades facial muscle function from I (normal) to VI (total paralysis).
- Higher scores indicate more severe dysfunction.
|
week 6
|
Facial Disability Index (FDI)
Time Frame: week 6
|
A patient-reported outcome measure assessing the impact of facial palsy on daily life.Assesses physical, social, and emotional functioning - Uses a questionnaire.
- Higher scores indicate a greater impact on daily life.
|
week 6
|
Sunnybrook Facial Grading System
Time Frame: week 6
|
An assessment tool for evaluating facial muscle function, including static and dynamic aspects.
|
week 6
|
Synkinesis Assessment Questionnaire (SAQ)
Time Frame: week 6
|
An assessment tool specifically designed to evaluate synkinesis- related symptoms.
Assesses the presence and severity of synkinesis symptoms during voluntary actions.
- Uses a questionnaire.
- Higher scores indicate more severe synkinesis-related symptoms.
|
week 6
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ayesha Afridi, PhD*, Riphah International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 22, 2024
Primary Completion (Estimated)
August 22, 2024
Study Completion (Estimated)
August 25, 2024
Study Registration Dates
First Submitted
March 25, 2024
First Submitted That Met QC Criteria
March 25, 2024
First Posted (Actual)
April 1, 2024
Study Record Updates
Last Update Posted (Actual)
April 1, 2024
Last Update Submitted That Met QC Criteria
March 25, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/01743
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bell Palsy
-
Universidad de la RepublicaCompleted
-
Lama Saad El-Din MahmoudCompletedBell's Palsy | Facial Nerve PalsyEgypt
-
Minia UniversityNot yet recruiting
-
The Third Affiliated hospital of Zhejiang Chinese...Zhejiang University; The First Affiliated Hospital of Zhejiang Chinese Medical...Not yet recruiting
-
University Hospital, MontpellierRecruiting
-
Oregon Health and Science UniversityTerminated
-
Fatih Sultan Mehmet Training and Research HospitalCompleted
-
Wenzhou Medical UniversityCompleted
-
Beijing Tongren HospitalCompleted
-
Riphah International UniversityCompleted
Clinical Trials on mime therapy
-
Superior UniversityRecruiting
-
Riphah International UniversityRecruiting
-
University of LahoreRecruiting
-
Riphah International UniversityCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruitingDisorder of Consciousness | Acquired Brain InjuryItaly
-
Riphah International UniversityCompleted
-
University of Alabama at BirminghamCompleted
-
Mennallah Ahmed Mohamed Anwar ElgendyNot yet recruiting
-
Universidad de ZaragozaCompletedPlagiocephaly | Plagiocephaly, Nonsynostotic | Plagiocephaly, PositionalSpain